Share

November 26, 2019; 93 (22) Resident & Fellow Section

Teaching NeuroImages: Autoimmune glial fibrillary acidic protein meningoencephalomyelitis

Paula K.J. Lee, Juan E. Small, Michal Vytopil
First published November 25, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008562
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
678

Share

A 73-year-old woman with myelodysplastic syndrome presented with 2 months of decline in cognition and mobility, accompanied by headache and weight loss. Examination revealed a somnolent woman with symmetric cogwheel rigidity, bradykinesia, arm myoclonus, and hyperreflexia. Brain MRI showed leptomeningeal, linear/stippled parenchymal, and ependymal enhancement (figure 1). Spine MRI demonstrated nonenhancing cervicothoracic cord signal change and circumferential enhancement of conus medullaris with central canal enhancement (figure 2). CSF was inflammatory with glial fibrillary acidic protein (GFAP)–immunoglobulin G (IgG). The patient responded promptly to IV methylprednisolone. GFAP-IgG identifies a severe but highly corticosteroid-responsive autoimmune meningoencephalomyelitis with distinctive MRI findings.1,2

Figure 1
Figure 1 Axial T1 postcontrast brain MRI

Leptomeningeal, linear/stippled parenchymal, and ependymal postgadolinium enhancement (arrows).

Figure 2
Figure 2 Thoracic sagittal T1 postcontrast MRI

Leptomeningeal (white arrows) and central canal enhancement (black arrows) throughout the cord (A) and conus medullaris (B). Axial T1 postcontrast image (C) with peripheral leptomeningeal enhancement and central dot of central spinal canal enhancement.

Study funding

No targeted funding reported.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Appendix Authors

Table

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Teaching slides links.lww.com/WNL/B2

References

  1. 1.↵
    1. Fang B,
    2. McKeon A,
    3. Hinson SR, et al
    . Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 2016;73:1297–1307.
    OpenUrl
  2. 2.↵
    1. Flanagan EP,
    2. Hinson SR,
    3. Lennon VA, et al
    . Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 2017;81:298–309.
    OpenUrl

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me